Compugen | CGEN - Ebitda





Ebitda Veränderung Datum
Arca Biopharma USD -25.07M 5.23M 2025-03
aTyr Pharma USD 34.92M 34.95M 2026-09
Bio Path USD -3.21M 631K 2025-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -8.84M 180K 2026-06
Immunic USD -22.78M 753K 2024-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
RedHill Biopharma USD 2.69M 108.46M 2023-06
TherapeuticsMD USD -1.64M 700K 2023-09